$100,000 research grant to study ovarian cancer stem cells

May 6, 2014

Dr. Barbara Vanderhyden has been granted $100,000 by the Canadian Institutes of Health Research (CIHR) to advance her work in the area of ovarian cancer stem cells. Her research focuses on better understanding the origins and development of ovarian cancer and the stem cells that lead to the growth of tumours in women’s reproductive system. Specifically, Dr. Vanderhyden’s research looks into the risk of developing ovarian cancer after ovulation has occurred and the ovary is repairing itself. Further details, including a list of co-investigators, can be found in CIHR’s Funding Decision Database.

About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.

Media contact
Paddy Moore
Communications and Public Relations
Ottawa Hospital Research Institute
613-737-8899 x73687
613-323-5680 (cell)